Lundbeck on track to meet financial expectations and renew its product portfolio to secure long-term growth
8 August 2012 | By H. Lundbeck A/S
H. Lundbeck A/S reports first half revenue of DKK 6,829 million...
List view / Grid view
News
Teva to initiate Third Phase III Trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
8 August 2012 | By Teva Pharmaceutical Industries Ltd
The clinical trial protocol has been granted a Special Protocol Assessment agreement...
Pfizer reduces its greenhouse gas emissions by 20 percent
8 August 2012 | By Pfizer
Company reaches five-year public goal a year earlier than anticipated...
Amgen announces termination of Ganitumab Phase 3 study for futility in metastatic pancreatic cancer
8 August 2012 | By Amgen
Amgen announced a decision to stop the ganitumab Phase 3 GAMMA trial...
Bristol-Myers Squibb announces successful completion of cash tender offer for shares of Amylin Pharmaceuticals, Inc.
8 August 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced the successful completion of the tender offer...
Pfizer announces resolutions with DOJ and SEC related to certain international operations
7 August 2012 | By Pfizer
U.S. agencies praise company’s cooperation and compliance program...
European Commission grants marketing authorisation for pazopanib (Votrient®)
7 August 2012 | By GlaxoSmithKline
The European Commission has granted pazopanib marketing authorisation...
Lilly announces study results regarding postmenopausal women with back pain caused by vertebral fractures
7 August 2012 | By Eli Lilly and Company
Eli Lilly and Company announced data from a Phase III trial...
Abbott’s Omnilink Elite® Vascular Balloon-Expandable Stent System receives FDA approval
7 August 2012 | By Abbott
The U.S. FDA has approved the Omnilink Elite® Vascular Balloon-Expandable Stent System...
Pfizer announces co-primary clinical endpoints not met in second Phase 3 Bapineuzumab Study
6 August 2012 | By Pfizer
Bapineuzumab IV Phase 3 program discontinued...
I Holland launch Die Contion Monitor
6 August 2012 | By I Holland
I Holland were very pleased by the reaction to the launch of the 'Holland Die Condition Monitor'...
Bristol-Myers Squibb Foundation awards $1.6 million in grants to help communities in India address type 2 diabetes
6 August 2012 | By Bristol-Myers Squibb Company
$1.6 million awarded in grants...
Novartis and University of Pennsylvania form broad-based R&D alliance to advance novel T-cell immunotherapies to treat cancer
6 August 2012 | By Novartis
Collaboration to study CAR technology...
GSK completes acquisition of Human Genome Sciences
3 August 2012 | By GlaxoSmithKline
GlaxoSmithKline has completed its acquisition of Human Genome Sciences for US$3.6 billion...
Study shows Toviaz is effective in reducing urge urinary incontinence in patients with overactive bladder after suboptimal response to Detrol LA
3 August 2012 | By Pfizer
Phase 4 study has met its primary endpoint...
